1. Home
  2. ASTI vs CRVO Comparison

ASTI vs CRVO Comparison

Compare ASTI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$3.07

Market Cap

40.9M

Sector

Technology

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$2.66

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
CRVO
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.9M
39.3M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
ASTI
CRVO
Price
$3.07
$2.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$20.00
$23.00
AVG Volume (30 Days)
376.9K
523.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
70.23
N/A
EPS
N/A
N/A
Revenue
$10,398,149.00
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.25
N/A
52 Week Low
$1.40
$2.13
52 Week High
$9.87
$11.25

Technical Indicators

Market Signals
Indicator
ASTI
CRVO
Relative Strength Index (RSI) 30.41 38.60
Support Level $1.42 $2.13
Resistance Level $4.68 $4.27
Average True Range (ATR) 0.28 0.26
MACD -0.02 -0.08
Stochastic Oscillator 4.36 3.36

Price Performance

Historical Comparison
ASTI
CRVO

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: